Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii®) in people with bipolar I disorder: a Plain Language Summary of Publication
- PMID: 39469110
- PMCID: PMC11514105
- DOI: 10.1177/20451253241278830
Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii®) in people with bipolar I disorder: a Plain Language Summary of Publication
Abstract
The purpose of this summary is to explain key findings from a study that included people with bipolar I disorder, as described in two separate articles (see the 'Further Information' section for more details). The study compared a new formulation of aripiprazole, given as an injection once every 2 months, with a once‑monthly injection of aripiprazole.
Keywords: antipsychotic; aripiprazole; bipolar I disorder; long-acting injectable.
© The Author(s), 2024.
Publication types
LinkOut - more resources
Full Text Sources
